These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 32424140)

  • 1. The proteasome activator REGγ accelerates cardiac hypertrophy by declining PP2Acα-SOD2 pathway.
    Xie Y; Gao Y; Gao R; Yang W; Dong Z; Moses RE; Sun A; Li X; Ge J
    Cell Death Differ; 2020 Oct; 27(10):2952-2972. PubMed ID: 32424140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 11S Proteasome Activator REGγ Promotes Aortic Dissection by Inhibiting RBM3 (RNA Binding Motif Protein 3) Pathway.
    Xie Y; Gao R; Gao Y; Dong Z; Ge J
    Hypertension; 2023 Jan; 80(1):125-137. PubMed ID: 36330811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The proteasome activator REGγ promotes diabetic endothelial impairment by inhibiting HMGA2-GLUT1 pathway.
    Xie Y; Gao R; Gao Y; Dong Z; Moses RE; Li X; Ge J
    Transl Res; 2022 Aug; 246():33-48. PubMed ID: 35367424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delphinidin attenuates pathological cardiac hypertrophy via the AMPK/NOX/MAPK signaling pathway.
    Chen Y; Ge Z; Huang S; Zhou L; Zhai C; Chen Y; Hu Q; Cao W; Weng Y; Li Y
    Aging (Albany NY); 2020 Mar; 12(6):5362-5383. PubMed ID: 32209725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SIRT4 accelerates Ang II-induced pathological cardiac hypertrophy by inhibiting manganese superoxide dismutase activity.
    Luo YX; Tang X; An XZ; Xie XM; Chen XF; Zhao X; Hao DL; Chen HZ; Liu DP
    Eur Heart J; 2017 May; 38(18):1389-1398. PubMed ID: 27099261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ATGL deficiency aggravates pressure overload-triggered myocardial hypertrophic remodeling associated with the proteasome-PTEN-mTOR-autophagy pathway.
    Han X; Zhang YL; Lin QY; Li HH; Guo SB
    Cell Biol Toxicol; 2023 Oct; 39(5):2113-2131. PubMed ID: 35218467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibroblast growth factor 21 protects the heart from angiotensin II-induced cardiac hypertrophy and dysfunction via SIRT1.
    Li S; Zhu Z; Xue M; Yi X; Liang J; Niu C; Chen G; Shen Y; Zhang H; Zheng J; Zhao C; Liang Y; Cong W; Wang Y; Jin L
    Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1241-1252. PubMed ID: 30677512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. De-ubiquitination of p300 by USP12 Critically Enhances METTL3 Expression and Ang II-induced cardiac hypertrophy.
    Lu P; Xu Y; Sheng ZY; Peng XG; Zhang JJ; Wu QH; Wu YQ; Cheng XS; Zhu K
    Exp Cell Res; 2021 Sep; 406(1):112761. PubMed ID: 34339675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin-(1-7) attenuates angiotensin II-induced cardiac hypertrophy via a Sirt3-dependent mechanism.
    Guo L; Yin A; Zhang Q; Zhong T; O'Rourke ST; Sun C
    Am J Physiol Heart Circ Physiol; 2017 May; 312(5):H980-H991. PubMed ID: 28411231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. REGγ deficiency promotes premature aging via the casein kinase 1 pathway.
    Li L; Zhao D; Wei H; Yao L; Dang Y; Amjad A; Xu J; Liu J; Guo L; Li D; Li Z; Zuo D; Zhang Y; Liu J; Huang S; Jia C; Wang L; Wang Y; Xie Y; Luo J; Zhang B; Luo H; Donehower LA; Moses RE; Xiao J; O'Malley BW; Li X
    Proc Natl Acad Sci U S A; 2013 Jul; 110(27):11005-10. PubMed ID: 23766372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zonisamide attenuates pressure overload-induced myocardial hypertrophy in mice through proteasome inhibition.
    Wu Q; Liu WJ; Ma XY; Chang JS; Zhao XY; Liu YH; Yu XY
    Acta Pharmacol Sin; 2024 Apr; 45(4):738-750. PubMed ID: 38097716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and regulation of type 2A protein phosphatases and alpha4 signalling in cardiac health and hypertrophy.
    Eleftheriadou O; Boguslavskyi A; Longman MR; Cowan J; Francois A; Heads RJ; Wadzinski BE; Ryan A; Shattock MJ; Snabaitis AK
    Basic Res Cardiol; 2017 Jul; 112(4):37. PubMed ID: 28526910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CSN6 aggravates Ang II-induced cardiomyocyte hypertrophy via inhibiting SIRT2.
    Mei ZL; Wang HB; Hu YH; Xiong L
    Exp Cell Res; 2020 Nov; 396(1):112245. PubMed ID: 32882218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PKA turnover by the REGγ-proteasome modulates FoxO1 cellular activity and VEGF-induced angiogenesis.
    Liu S; Lai L; Zuo Q; Dai F; Wu L; Wang Y; Zhou Q; Liu J; Liu J; Li L; Lin Q; Creighton CJ; Costello MG; Huang S; Jia C; Liao L; Luo H; Fu J; Liu M; Yi Z; Xiao J; Li X
    J Mol Cell Cardiol; 2014 Jul; 72():28-38. PubMed ID: 24560667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The immunoproteasome catalytic β5i subunit regulates cardiac hypertrophy by targeting the autophagy protein ATG5 for degradation.
    Xie X; Bi HL; Lai S; Zhang YL; Li N; Cao HJ; Han L; Wang HX; Li HH
    Sci Adv; 2019 May; 5(5):eaau0495. PubMed ID: 31086810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. REGgamma proteasome activator is involved in the maintenance of chromosomal stability.
    Zannini L; Lecis D; Buscemi G; Carlessi L; Gasparini P; Fontanella E; Lisanti S; Barton L; Delia D
    Cell Cycle; 2008 Feb; 7(4):504-12. PubMed ID: 18235248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BRD4 blockage alleviates pathological cardiac hypertrophy through the suppression of fibrosis and inflammation via reducing ROS generation.
    Zhu W; Wu RD; Lv YG; Liu YM; Huang H; Xu JQ
    Biomed Pharmacother; 2020 Jan; 121():109368. PubMed ID: 31707348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Site-specific acetylation of the proteasome activator REGγ directs its heptameric structure and functions.
    Liu J; Wang Y; Li L; Zhou L; Wei H; Zhou Q; Liu J; Wang W; Ji L; Shan P; Wang Y; Yang Y; Jung SY; Zhang P; Wang C; Long W; Zhang B; Li X
    J Biol Chem; 2013 Jun; 288(23):16567-16578. PubMed ID: 23612972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidative challenge enhances REGγ-proteasome-dependent protein degradation.
    Zhang Y; Liu S; Zuo Q; Wu L; Ji L; Zhai W; Xiao J; Chen J; Li X
    Free Radic Biol Med; 2015 May; 82():42-9. PubMed ID: 25656993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. REGgamma, a proteasome activator and beyond?
    Mao I; Liu J; Li X; Luo H
    Cell Mol Life Sci; 2008 Dec; 65(24):3971-80. PubMed ID: 18679578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.